戻る Agenda
Postmarketing and Risk Management
Session Chair(s)
Sumant Ramachandra, MD, PHD, MBA
Chief Scientific Officer & Senior VP of R&D and Medical Regulatory Affairs
Hospira, Inc., United States
Speaker(s)
Post-marketing Requirements and Pharmacovigilance
Freddy J Faccin
AbbVie, Puerto Rico
Assoc. Medical Director, Lat. America Biotherapeutics, Immunology Medical Affair
Trending, Signal Detection and Risk
Juergen Schmider, MD, PHD
Pfizer Inc., United States
Vice President, Pharmacovigilance & Safety Evaluation and Reporting
Panel Discussion - Additional Speaker
Martina Weise, DrMed, MD
Bfarm, Germany
Head, Licensing Division 2, BfArM; German CHMP Alternate